RESEARCH TRIANGLE PARK, NC--(Marketwire - August 19, 2008) - Business intelligence firm
Cutting Edge Information announces the release of its new study on alliance
management in the drug industry.
The report, "Pharmaceutical Alliance Management," focuses exclusively on
post-deal management of collaborations focused on drug development and
marketing. It explores alliance management strategies, best practices and
processes. The research findings center on structures, resources and
tools; partnership health measurement; conflict resolution; project
coordination; and partner-of-choice status.
A complimentary report brochure is available for immediate download here:
http://www.cuttingedgeinfo.com/pharmadealmaking/PH119_Download.asp#body
"Companies spend considerable time and energy in closing a deal," said Eric
Bolesh, lead author of the report, "But too often, partnerships lose
momentum or even fail because of difficulties with ongoing alliance
management tasks. Allowing this to happen is a great risk, as partnerships
are crucial to companies' portfolio management and to the bottom line."
"Pharmaceutical Alliance Management" provides guidelines for effective
partner communication and internal coordination to ensure continuous
alliance satisfaction.
The report helps alliance management personnel to improve in all areas
critical to maintaining partnership success -- building stakeholders'
support, developing solid strategies from the outset, cultivating strong
relationships, measuring alliance ROI, minimizing conflict, coordinating
projects, and establishing and leveraging a reputation as a preferred
partner.
Developed from surveys and interviews with pharmaceutical and biotechnology
industry leaders, the study identifies post-deal challenges and outlines
solutions. Surveyed companies reveal innovative strategies and tactics for
avoiding common problems.
More than 50 companies contributed to the study, which contains 150+
metrics, including the following:
-- Resource support for alliance management groups
-- Prevalence of dedicated alliance management functions, by company size
-- Levels of historical deal satisfaction
-- Underlying reasons for unsuccessful deals
-- Key deal challenges
-- Inbound deals: functions involved in post-deal day-to-day activities
-- Outbound deals: functions involved in post-deal day-to-day activities
-- Use of alliance health surveys
-- Tools of the alliance health department
-- Surveyed companies' communication models
-- Steps to partner-of-choice status
Whereas "Pharmaceutical Alliance Management" concentrates on post-deal
management, another CEI report -- "Business Development: Accelerating the
Deal" -- analyzes resources, strategies and best practices of the earlier
stages of the deal-making process. For more information on business
development's role in identifying, exploring and negotiating deals, please
visit
www.PharmaDealMaking.com.
Contact Information: CONTACT INFORMATION:
Eric Bolesh
919-433-0209